Observational Study of Characteristics, Treatment and Outcomes with Severe Asthma in the United States (CHRONICLE)

Study identifier:D3250R00023

ClinicalTrials.gov identifier:NCT03373045

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

The CHRONICLE Study: A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals with Severe Asthma in the United States

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

275

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 27 Feb 2018
Estimated Primary Completion Date: 15 Feb 2025
Estimated Study Completion Date: 15 Feb 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -

Verification:

Verified 01 Nov 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

PAREXEL, MedImmune

Inclusion and exclusion criteria